ANXIETY is the #8 most commonly reported adverse reaction for METOCLOPRAMIDE HYDROCHLORIDE, manufactured by ANI Pharmaceuticals, Inc.. There are 4,053 FDA adverse event reports linking METOCLOPRAMIDE HYDROCHLORIDE to ANXIETY. This represents approximately 2.0% of all 206,778 adverse event reports for this drug.
Patients taking METOCLOPRAMIDE HYDROCHLORIDE who experience anxiety should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
ANXIETY4,053 of 206,778 reports
ANXIETY is a less commonly reported adverse event for METOCLOPRAMIDE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
Other Side Effects of METOCLOPRAMIDE HYDROCHLORIDE
In addition to anxiety, the following adverse reactions have been reported for METOCLOPRAMIDE HYDROCHLORIDE:
ANXIETY has been reported as an adverse event in 4,053 FDA reports for METOCLOPRAMIDE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is ANXIETY with METOCLOPRAMIDE HYDROCHLORIDE?
ANXIETY accounts for approximately 2.0% of all adverse event reports for METOCLOPRAMIDE HYDROCHLORIDE, making it a notable side effect.
What should I do if I experience ANXIETY while taking METOCLOPRAMIDE HYDROCHLORIDE?
If you experience anxiety while taking METOCLOPRAMIDE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.